M ENZALUTAMIDE (is an active metabolite) | ENZALUTAMIDE | ATC L02BB04
ANTINEOPLASTIC ANDROGEN RECEPTOR INHIBITOR TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER DECREASED PROLIFERATION AND INDUCED CELL DEATH | - | Cmax 28.2 MICROMOLAR VD 288 LITER (EQN) PPB 95 PERCENT Cl 1.02 LITER / HOUR HT 196 HOUR | ANDROGEN RECEPTOR (AR) | ANDROGEN RECEPTOR ANTAGONIST CHEMBL1871 ANDROGEN RECEPTOR P10275 ANDROGEN RECEPTOR HOMO SAPIENS TRANSCRIPTION FACTOR NUCLEAR RECEPTOR NR3 NR3C NR3C4 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |